Drug recall

Platelets Pheresis Leukoreduced

FDA recall event 27099 · Class II · Carter BloodCare

Key facts

Event ID 27099
Recall numbers B-1846-3
Recalling firm Carter BloodCare
Product type Biologics
Products Platelets Pheresis Leukoreduced
Classification Class II
Status Completed
Voluntary or mandated Firm Initiated
Reason for recall Blood product, which was collected from a donor who had taken aspirin within three days of donation, was distributed.
Initiation date Mar 24, 2003
City Bedford
Country United States
FEI number 3002603147

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls